Tel：
(86)(21)60969600
Add: Building 28, Lane 588, Tianxiong Road. Shanghai, P. R. China
Recently, Shanghai MicroPort EP MedTech Co., Ltd. (referred to as "MicroPort EP") has successfully completed the first batch of clinical applications of its EasyLoop™ 3D Single-Use Magnetic Localization Circular Mapping Catheter (hereinafter referred to as "EasyLoop™ 3D Circular Mapping Catheter") in Italy, France, Switzerland, and Turkey. This catheter, when used in conjunction with the Columbus™ 3D EP Navigation System (referred to as "Columbus™ System") and the FireMagic™ TrueForce™ Ablation Catheter (referred to as "TrueForce™ Ablation Catheter"), provides a safer, more efficient, and precise solution for the treatment of complex arrhythmias such as atrial fibrillation. This successful application marks the official entry of a complete set of domestic solutions for complex arrhythmias into the international market, serving patients worldwide.
During these landmark procedures, Dr. Giosesuè Mascioli, a leading electrophysiology expert from Desenzano del Garda Hospital in Italy, and his team successfully utilized the Columbus™ System in conjunction with the EasyLoop™ 3D Circular Mapping Catheter and the TrueForce™ Ablation Catheter to complete two atrial fibrillation treatment procedures. After the procedures, Dr. Giosesuè Mascioli highly recognized the safety and effectiveness of the EasyLoop™ 3D Circular Mapping Catheter during the procedures. He noted that compared to traditional 2D catheters, the visualization capabilities of the EasyLoop™ 3D Circular Mapping Catheter on the Columbus™ System significantly enhanced the precision of identifying pulmonary vein leakage points. This not only improved the efficiency of pulmonary vein isolation but also significantly reduced X-ray exposure. Through these initial clinical procedures, Dr. Giosesuè Mascioli expressed sincere appreciation for MicroPort EP's research and development achievements.
Atrial fibrillation (AF) is a common clinical arrhythmia characterized by the loss of regular and orderly electrical activity in the atria, replaced by rapid and disorganized fibrillation waves, representing a severe disturbance of atrial electrical activity. This condition not only affects the normal function of the heart but also increases the risk of thrombus formation and stroke. Data shows that the prevalsence of AF increases with age, with more than 10% of individuals over 80 years old affected. AF can increase all-cause mortality by 1.5 to 3.5 times, imposing significant health impacts and economic burdens on patients and their families, making it a global public health issue that urgently needs addressing.
Catheter radiofrequency ablation guided by high-density mapping has emerged as one of the advanced techniques for treating AF. MicroPort EP's self-developed EasyLoop™ 3D Circular Mapping Catheter, based on magnetic-electric fusion localization technology, enables real-time and precise visualization on the Columbus™ System. During the procedure, doctors use the EasyLoop™ 3D Circular Mapping Catheter to quickly and accurately construct a 3D model of the patient's left atrium and clearly record pulmonary vein potential information. The visualization of the circular electrode can rapidly and effectively detect pulmonary vein leakage points, and when combined with the TrueForce™ Ablation Catheter for quantitative ablation, it significantly enhances surgical efficiency.
Since its establishment, MicroPort EP has been dedicated to the research and development of innovative medical devices in the field of electrophysiology interventional diagnosis and treatment, continuously introducing internationally competitive new products. The company's first domestically developed pressure monitoring magnetic localization radiofrequency ablation catheter and Columbus™ System have already entered overseas markets, with their outstanding performance and stable performance earning positive market feedback and clinical recognition. The successful application of the EasyLoop™ 3D Circular Mapping Catheter, combined with the existing TrueForce™ Ablation Catheter and Columbus™ System, forms a complete layout of domestic solutions for complex arrhythmias in overseas markets.
In the future, MicroPort EP will actively expand its global reach, providing more comprehensive products and professional services to patients and physicians, offering a globally competitive integrated solution for electrophysiology intervention diagnosis and treatment.
